Quote:THE MEDIA MUST STOP LIVE -BROADCASTING TRUMP'S DANGEROUS, DESTRUCTIVE CORONAVIRUS BRIEFINGS
By Margaret Sullivan
March 21, 2020
More and more each day, President Trump is using his daily briefings as a substitute for the campaign rallies that have been forced into extinction by the spread of the novel coronavirus.
These White House sessions — ostensibly meant to give the public critical and truthful information about this frightening crisis — are in fact working against that end.
Rather, they have become a daily stage for Trump to play his greatest hits to captive audience members. They come in search of life-or-death information, but here’s what they get from him instead:
Self-aggrandizement. When asked how he would grade his response to the crisis, the president said, “I’d rate it a 10.” Absurd on its face, of course, but effective enough as blatant propaganda
Media-bashing. When NBC News’s Peter Alexander lobbed him a softball question in Friday’s briefing — “What do you say to Americans who are scared?” — Trump went on a bizarre attack. “I say, you’re a terrible reporter,” the president said, launching into one of his trademark “fake news” rants bashing Alexander’s employer. (Meanwhile, he has also found time during these news briefings to lavish praise on sycophantic pro-Trump media like One America News Network, whose staffer — I can’t call her a reporter — invited him to justify his xenophobic talk of a “Chinese virus” by asking rhetorically if he considers the phrase “Chinese food” racist.)
NBC’s Peter Alexander asked Trump to reassure Americans about coronavirus. Trump berated him instead.
Exaggeration and outright lies. Trump has claimed that there are plenty of tests available (there aren’t); that Google is “very quickly” rolling out a nationwide website to help manage coronavirus treatment (the tech giant was blindsided by the premature claim); that the drug chloroquine, approved to treat malaria, is a promising cure for the virus and “we’re going to be able to make that drug available almost immediately.” (It hasn’t been approved for this use, and there is no evidence to demonstrate its effectiveness in fighting the virus.)
Trump is doing harm and spreading misinformation while working for his own partisan political benefit — a naked attempt to portray himself as a wartime president bravely leading the nation through a tumultuous time, the FDR of the 21st century.
The press — if it defines its purpose as getting truthful, useful, non-harmful information to the public, as opposed to merely juicing its own ratings and profits — must recognize what is happening and adjust accordingly. (And that, granted, is a very big “if.”)
Business as usual simply doesn’t cut it. Minor accommodations, like fact-checking the president’s statements afterward, don’t go nearly far enough to counter the serious damage this man is doing to the public’s well-being.
Radical change is necessary: The cable networks and other news organizations that are taking the president’s briefings as live feeds should stop doing so.
Should they cover the news that’s produced in them? Of course. Thoroughly and relentlessly — with context and fact-checking built in to every step and at every stage.
“There is a very real possibility that in broadcasting these press conferences live or in quickly publishing and blasting out his words in mobile alerts, we are actively misinforming our audience,” Alex Koppelman, managing editor of CNN Business, wrote in an email for the network’s Reliable Sources newsletter.
Koppelman stopped short of overtly calling for the radical solution. That’s not so for Jay Rosen, a journalism professor at New York University who wrote on his PressThink blog that the media needs to switch into “emergency mode” for covering Trump and clearly communicate that change to its readers and viewers.
“We are not obliged to assist him in misinforming the American public about the spread of the virus, and what is actually being done by his government,” Rosen wrote.
Rather than covering Trump live, he recommended, among other things, that the media should “attend carefully to what he says” and subject it to verification before blasting it out to the public.
It’s important to remember how much Trump’s tune has changed on the coronavirus, from blithely dismissive to self-importantly serious.
This is what he was saying about the virus in public as recently as Feb. 27: “It’s going to disappear. One day — it’s like a miracle — it will disappear.”
We know, without any doubt, that Trump was ignoring intelligence reports that warned about the likelihood of a pandemic at the same time he was cooing these baseless reassurances. But now he’s claiming that he knew the problem was a pandemic long before others did, and that he took every step possible.
Will people remember the depths of his mendacity and hold him accountable?
“I’m worried about our collective memory when it comes to this,” Charlie Warzel of the New York Times wrote on Saturday. It is this initial lack of action that will cost lives months down the road, he noted.
Therefore, “accountability will mean not giving into recency bias when this ends and remembering how it got so bad in the first place.”
There’s a strong counter-argument to be made, of course: that the press shouldn’t be in the business of shielding the public from the president’s statements — no matter how misleading, xenophobic or damaging.
It’s a persuasive argument, and one I wish I could still believe in.
But Trump has proved, time after time, that he doesn’t care about truth, that he puts his financial and political self-interest above that of the public, and that he has no understanding of the role of the press in a democracy. And now lives are on the line.
The news media, at this dangerous and unprecedented moment in world history, must put the highest priority on getting truthful information to the public.
Taking Trump’s press conferences as a live feed works against that core purpose.
-washingtonpost.com
https://www.washingtonpost.com/lifestyle/medi...story.html
THE MEDIA MUST STOP LIVE -BROADCASTING TRUMP'S DANGEROUS,
Top 10 Most Recent News Articles
Perpetua's Bold Moves Elevate Idaho's Stibnite Gold Project
Perpetua Resources Sparking New Conversations Alright, fasten your seatbelts, folks—Perpetua Resources is causing a buzz with its Stibnite Gold Project. If you blink, you might miss what's happening down in Idaho. They've started throwing some serious weight around with fresh gold discoveries that not only promise ounces but maybe some juicy returns for those keeping a...
Continue Reading
Nuvo's INVU™ Trial Reveals Boost in Fetal Monitoring
Remote Fetal Monitoring: A Game Changer in Prenatal Care? In the world of high-risk pregnancies, routine checkups aren't just a suggestion—they're vital. But when the logistics of shuttling back and forth to clinics get tangled with everyday life, something's gotta give. Enter Nuvo's INVU™. The REACTIVE trial, a Penn Medicine-led event funded by the NIH, aimed to see...
Continue Reading
NetEase Awaits Q3 2026 Results: What's at Stake?
D-Day for NetEase: Quarterly Results Incoming We're inching closer to November 19, 2026, and if you hold a piece of NetEase (NASDAQ: NTES), you're probably on pins and needles. This is when the curtains rise on their third-quarter financial results, which they've been fiercely guarding like a high-stakes poker hand. They'll be laying it all out right before the U.S....
Continue Reading
Global Leaders Unite to Tackle Major World Challenges
Gathering Minds in Washington: A Summit to Remember Let me tell you straight – when over a hundred heavyweights from government, finance, and tech get in the same room, you bet people start paying attention. We’re talking about the 2026 WICE Global Impact Summit that went down at The Penthouse in The Washington Post Building. The movers and shakers weren't there to...
Continue Reading
NativeSeed Group Expands with Sharp Brothers Buyout
A Quiet Giant Grows Stronger Who would've thought? While most folks are caught up watching tech stocks or energy commodities spike, NativeSeed Group just made a move worth raising an eyebrow over. On November 5, 2026, they scooped up the assets of Sharp Brothers Seed Company, a small firm in Healy, Kansas known for top-tier native seed cleaning. We've got ourselves a...
Continue Reading
AI Data Center Market to Hit USD 84.52B by 2032
Gearing Up for an AI Data Center Boom Tell me something, when did data centers become the rock stars of tech infrastructure? There’s fire in the belly of the Global AI Data Center Market, which is on a meteoric trajectory. Picture the numbers: we’re staring down the barrel of more than USD 84.52 billion by 2032, racing forward at an impressive CAGR of 25.8% from 2026,...
Continue Reading
Atlas Ocean Expands with New Epic Journeys for 2027-28
Atlas Ocean Voyages' Grand Plans Anyone who's been sailing this rocky market sea long enough knows there’s no better place to gauge the winds than from a cozy captain's chair—so picture this: Atlas Ocean Voyages just dropped a 2027-28 roadmap that’s more of an atlas in its own right. We’re talking epic voyages spanning Europe, the Med, and Arctic realms, all while...
Continue Reading
Harbour BioMed's Strategic Nudge with Vivian Feng Hire
A Refreshing Jolt for Harbour BioMed's Growth Journey Harbour BioMed just threw down a new card by bringing in Ms. Vivian Feng as the Senior Vice President, Head of External Collaboration. There's a real sense of drive coming from this decision. When a biopharma outfit asserts its intent to ramp up growth, and they hang the hat on someone like Vivian, you better believe...
Continue Reading
AI in Healthcare: Real Results Unveiled at HLTH 2026
Transforming Healthcare with AI The landscape of healthcare is constantly evolving, and this time, we're diving deep into how AI is shaking things up. MCG Health and Telligen, both heavyweights in the health sector, are stepping into the limelight at the HLTH 2026 conference. This ain't just any run-of-the-mill presentation; it's where the rubber meets the road in...
Continue Reading
Slide Stainers Market Reaches $7.39B Forecast By 2031
Slide Stainers Market Growth: A Closer Look In a world where precision and speed define medical success, the Slide Stainers Market is the silent hero no one talks about at cocktail parties. But make no mistake, its forecasted growth to $7.39 billion by 2031 shouts volumes in boardrooms and labs alike. With a modest start at $5.15 billion in 2026, this market is expected...
Continue ReadingTop 5 Most Recently Viewed Articles
Beneficient's Transformative Fiscal Year: Key Financial Insights
Beneficient's Transformative Year: Overview of Fiscal 2025 Beneficient (NASDAQ: BENF), a pioneering technology-enabled platform focused on revolutionizing the alternative asset investment landscape, has shared significant developments from its fiscal year ended March 31, 2025. The company has made strides in operational efficiencies, reduced costs, and launched innovative...
Continue Reading
Education as a Catalyst for Ending Leprosy Stigma Worldwide
Empowering Through Education: A Global Appeal The call to action from the Global Appeal to End Stigma and Discrimination Against Persons Affected by Leprosy underscores a significant truth: education is a powerful tool that can change lives. Recently launched in Brussels, this initiative celebrated its 21st year with renewed vigor, emphasizing the critical role education...
Continue Reading
Investigation Launched into Albany International Corporation on Behalf of Investors
Investigation into Albany International Corporation Albany International Corporation has become the subject of an investigation led by the law firm Kirby McInerney LLP. The firm aims to represent the interests of investors who may have been affected by potential violations of federal securities laws by the company or its officers. Details Regarding the Investigation This...
Continue Reading
Banijay Group Reports Its Weekly Share Transactions
Weekly Share Transactions of Banijay Group Banijay Group N.V. recently disclosed its share transactions, which are vital for investors and stakeholders eager to understand the company's performance and shareholder engagements. In compliance with the authority granted during the previous shareholders' annual meeting, these transactions were conducted from early June,...
Continue Reading
Iridex's Innovative Study on MicroPulse Treatment for DME
Revolutionizing Diabetic Macular Edema Treatment MOUNTAIN VIEW, Calif. – Iridex Corporation (Nasdaq: IRIX), a leader in laser-based medical systems, has taken a remarkable step forward in the treatment of diabetic macular edema (DME). The company recently announced the successful enrollment of the first patient in the DAME Trial. This pivotal study aims to assess the...
Continue Reading